March 15, 2019

Features

My Patient Has Glaucoma...Now What?

After a clinical examination and testing, your diagnosis is confirmed. Now, it’s time to develop a management plan. Here’s how.

Can You Spot These Retinal Vascular Abnormalities?

Abnormal changes in the retinal vasculature are closely linked with underlying systemic conditions—impacting both the physical and ocular health of the patient.

Anti-VEGF: Where Are We Now?

This review looks into the years of research on this versatile class of medications and turns an eye to its future.

Dry Eye Drugs: New Approaches to an Old Problem

Its multifactoral and variable nature makes DED a challenging condition to manage. These novel therapeutics are here to help.

Red Eye Roundup

This symptom could be a harbinger of many conditions. Here’s a look at the common causes and what to do about them.

The Changing Landscape of Glaucoma Therapy

The future looks promising with the recent introduction of new treatment options.

Anti-VEGF: Where Are We Now?

This review looks into the years of research on this versatile class of medications and turns an eye to its future.

Departments

Let the Truth Set You Free

Quit worrying about number one or number two. We have bigger truths to face, like that golf shirt you are wearing.

Don’t Bet on Red

Know how to use OCT data to decide whether a patient truly has glaucoma.

Glaucoma Tools: Know the New Codes

Increased use of new diagnostic technology led to changes that impact your workup.

Twice the Conditions, Twice the Fun

While the presence of other corneal abnormalities makes things difficult for this keratoconus patient, CXL should be initiated as soon as disease progression is detected.

A 67-year-old black female reported to the office with a chief complaint of blurry vision at near, as well as facial skin lesions. She asked if there was any medication that could improve her skin cosmesis.